Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Loennechen

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Pharmacology and Therapeutics|August 15, 2001
Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern NorwayT Loennechen, E Utsi, I Hartz, et al.
Pediatric Hematology and Oncology|January 1, 1989
Effects of 3-deazaadenosine, an inducer of HL-60 cell differentiation, on human blood cells in vitroS Prytz, T Loennechen, A Johansson, et al.
Biochimica Et Biophysica Acta|March 26, 1998
Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sitesO M Seternes, R Sørensen, B Johansen, et al.
Pharmacology & Toxicology|December 13, 1997
Effects of 3-deazaadenosine on apoptosis-related gene transcripts in HL-60 cellsT Loennechen, U Moens, H Kildalsen, et al.
Anticancer Research|December 22, 1998
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPLK Andersen, G M Maelandsmo, E Hovig, et al.
Clinical Pharmacology and Therapeutics|January 1, 1992
Interethnic difference in thiopurine methyltransferase activityB Klemetsdal, E Tollefsen, T Loennechen, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humansT Loennechen, C R Yates, M Y Fessing, et al.
The International Journal of Neuroscience|December 1, 1984
Mass spectrometric studies of some synaptosomal and synthetic peptidesK M Marnela, E A Hagen, A J Aasen, et al.
Cancer Research|September 24, 1999
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozymeK Bjørnland, J O Winberg, O T Odegaard, et al.
American Journal of Human Genetics|April 1, 1996
Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in CaucasiansH L Tai, E Y Krynetski, C R Yates, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology and Therapeutics|August 15, 2001
Detection of one single mutation predicts thiopurine S-methyltransferase activity in a population of Saami in northern NorwayT Loennechen, E Utsi, I Hartz, et al.
Pediatric Hematology and Oncology|January 1, 1989
Effects of 3-deazaadenosine, an inducer of HL-60 cell differentiation, on human blood cells in vitroS Prytz, T Loennechen, A Johansson, et al.
Biochimica Et Biophysica Acta|March 26, 1998
Synergistic increase in c-fos expression by simultaneous activation of the ras/raf/map kinase- and protein kinase A signaling pathways is mediated by the c-fos AP-1 and SRE sitesO M Seternes, R Sørensen, B Johansen, et al.
Pharmacology & Toxicology|December 13, 1997
Effects of 3-deazaadenosine on apoptosis-related gene transcripts in HL-60 cellsT Loennechen, U Moens, H Kildalsen, et al.
Anticancer Research|December 22, 1998
Interleukin-1 alpha and basic fibroblast growth factor induction of matrix metalloproteinases and their inhibitors in osteosarcoma cells is modulated by the metastasis associated protein CAPLK Andersen, G M Maelandsmo, E Hovig, et al.
Clinical Pharmacology and Therapeutics|January 1, 1992
Interethnic difference in thiopurine methyltransferase activityB Klemetsdal, E Tollefsen, T Loennechen, et al.
Clinical Pharmacology and Therapeutics|August 8, 1998
Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humansT Loennechen, C R Yates, M Y Fessing, et al.
The International Journal of Neuroscience|December 1, 1984
Mass spectrometric studies of some synaptosomal and synthetic peptidesK M Marnela, E A Hagen, A J Aasen, et al.
Cancer Research|September 24, 1999
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozymeK Bjørnland, J O Winberg, O T Odegaard, et al.
American Journal of Human Genetics|April 1, 1996
Thiopurine S-methyltransferase deficiency: two nucleotide transitions define the most prevalent mutant allele associated with loss of catalytic activity in CaucasiansH L Tai, E Y Krynetski, C R Yates, et al.
Pageof 3